JP2013540776A5 - - Google Patents

Download PDF

Info

Publication number
JP2013540776A5
JP2013540776A5 JP2013533942A JP2013533942A JP2013540776A5 JP 2013540776 A5 JP2013540776 A5 JP 2013540776A5 JP 2013533942 A JP2013533942 A JP 2013533942A JP 2013533942 A JP2013533942 A JP 2013533942A JP 2013540776 A5 JP2013540776 A5 JP 2013540776A5
Authority
JP
Japan
Prior art keywords
cyclosporin
sar
chr
compound
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013533942A
Other languages
English (en)
Japanese (ja)
Other versions
JP5805774B2 (ja
JP2013540776A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/055791 external-priority patent/WO2012051194A1/en
Publication of JP2013540776A publication Critical patent/JP2013540776A/ja
Publication of JP2013540776A5 publication Critical patent/JP2013540776A5/ja
Application granted granted Critical
Publication of JP5805774B2 publication Critical patent/JP5805774B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013533942A 2010-10-12 2011-10-11 シクロスポリンアナログ Expired - Fee Related JP5805774B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39244910P 2010-10-12 2010-10-12
US61/392,449 2010-10-12
PCT/US2011/055791 WO2012051194A1 (en) 2010-10-12 2011-10-11 Cyclosporin analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015173082A Division JP6250608B2 (ja) 2010-10-12 2015-09-02 シクロスポリンアナログ

Publications (3)

Publication Number Publication Date
JP2013540776A JP2013540776A (ja) 2013-11-07
JP2013540776A5 true JP2013540776A5 (cg-RX-API-DMAC7.html) 2013-12-26
JP5805774B2 JP5805774B2 (ja) 2015-11-10

Family

ID=44883784

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013533942A Expired - Fee Related JP5805774B2 (ja) 2010-10-12 2011-10-11 シクロスポリンアナログ
JP2015173082A Expired - Fee Related JP6250608B2 (ja) 2010-10-12 2015-09-02 シクロスポリンアナログ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015173082A Expired - Fee Related JP6250608B2 (ja) 2010-10-12 2015-09-02 シクロスポリンアナログ

Country Status (13)

Country Link
US (3) US20120088734A1 (cg-RX-API-DMAC7.html)
EP (1) EP2627664B1 (cg-RX-API-DMAC7.html)
JP (2) JP5805774B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140026329A (cg-RX-API-DMAC7.html)
CN (1) CN103328497A (cg-RX-API-DMAC7.html)
AU (1) AU2011316690C1 (cg-RX-API-DMAC7.html)
BR (1) BR112013008864A2 (cg-RX-API-DMAC7.html)
CA (1) CA2814192A1 (cg-RX-API-DMAC7.html)
IL (1) IL225617A0 (cg-RX-API-DMAC7.html)
MX (1) MX2013004061A (cg-RX-API-DMAC7.html)
RU (1) RU2013119869A (cg-RX-API-DMAC7.html)
SG (1) SG189880A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012051194A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9573978B2 (en) 2010-08-12 2017-02-21 S&T Global, Inc. Cyclosporin derivatives for the treatment and prevention of a viral infection
WO2012051194A1 (en) * 2010-10-12 2012-04-19 Allergan, Inc. Cyclosporin analogs
CN103261212A (zh) 2010-10-12 2013-08-21 阿勒根公司 环孢菌素类似物
US9890198B2 (en) * 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
AU2011342284C1 (en) * 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
CN104487449A (zh) * 2012-06-01 2015-04-01 阿勒根公司 环孢菌素a类似物
GB201222455D0 (en) * 2012-12-13 2013-01-30 Perioc Ltd Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
WO2014138437A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Steroid conjugates
WO2016112321A1 (en) 2015-01-08 2016-07-14 Allergan, Inc. Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
EP3277704A1 (en) 2015-03-31 2018-02-07 Allergan, Inc. Cyclosporins modified on the mebmt sidechain by heterocyclic rings
JP2019518745A (ja) * 2016-05-17 2019-07-04 エス アンド ティー グローバル インク. 新規シクロスポリン誘導体及びその使用
US20180193003A1 (en) 2016-12-07 2018-07-12 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
US11523772B2 (en) 2016-12-14 2022-12-13 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with an immunosuppressant
US20230041197A1 (en) 2018-06-20 2023-02-09 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator
WO2021173474A1 (en) * 2020-02-26 2021-09-02 Bacainn Biotherapeutics, Ltd. Cyclosporine compositions and methods of use
CN113173974B (zh) * 2021-03-18 2024-09-06 北京大学深圳研究生院 环孢素衍生物的合成方法
WO2024254480A2 (en) * 2023-06-08 2024-12-12 Hepion Pharmaceuticals, Inc. Solid state forms of rencofilstat
CN118834148B (zh) * 2024-09-20 2025-01-21 天津凯莱英制药有限公司 一种l-青霉胺的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5474979A (en) * 1994-05-17 1995-12-12 Allergan, Inc. Nonirritating emulsions for sensitive tissue
FR2757521B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757522B1 (fr) 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2762843B1 (fr) 1997-04-30 1999-12-10 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
HUP0102833A3 (en) * 1998-06-12 2002-03-28 Chem Ag C Cyclosporins, process for preparation thereof and their use
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7676680B2 (en) 2005-07-08 2010-03-09 Morgan Stanley Systems and methods for distributing private placement documents
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
DK2023918T3 (da) 2006-05-19 2011-04-26 Scynexis Inc Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
CN101130058B (zh) * 2006-08-23 2011-10-05 华北制药集团新药研究开发有限责任公司 一种环孢菌素a眼用乳剂及其制备方法
CN101687013A (zh) * 2007-05-04 2010-03-31 阿勒根公司 环孢菌素在治疗具有人工晶状体的患者中的用途
BRPI0915552A2 (pt) * 2008-07-10 2017-06-20 Allergan Inc derivados de ciclosporina, seu uso e sua composição farmacêutica
WO2012003077A1 (en) * 2010-07-02 2012-01-05 Exxonmobil Upstream Research Company Low emission triple-cycle power generation systems and methods
US8902844B2 (en) 2010-07-06 2014-12-02 Lg Electronics Inc. Method and device for allocating wireless resources for a machine type communication device in a wireless communication system
WO2012051194A1 (en) * 2010-10-12 2012-04-19 Allergan, Inc. Cyclosporin analogs
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
ES2625502T3 (es) * 2010-12-03 2017-07-19 S&T Global Inc Nuevos derivados de ciclosporina para el tratamiento y prevención de una infección vírica
CN103987399A (zh) * 2011-08-19 2014-08-13 美国科技环球有限公司 用于治疗和预防病毒感染的新型环孢菌素衍生物

Similar Documents

Publication Publication Date Title
JP2013540776A5 (cg-RX-API-DMAC7.html)
RU2013119869A (ru) Аналоги циклоспорина
US9309224B2 (en) N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
CN101610772B (zh) 包含吡嗪衍生物的药物组合物和使用吡嗪衍生物的联合用药的方法
JP7665619B2 (ja) 線維性疾患の治療に使用するためのアゼチジンlpa1受容体アンタゴニストのピルフェニドン及び/又はニンテダニブとの合剤
JP2020510015A5 (cg-RX-API-DMAC7.html)
JP2014525427A5 (cg-RX-API-DMAC7.html)
CN113831301B (zh) 苯并噻唑类衍生物及其用途
JP2019014758A5 (cg-RX-API-DMAC7.html)
TWI710555B (zh) 新穎水溶性前藥
JP2006515585A5 (cg-RX-API-DMAC7.html)
RU2011136250A (ru) Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство
JP2005528443A5 (cg-RX-API-DMAC7.html)
JP2006509749A5 (cg-RX-API-DMAC7.html)
JP2009532417A5 (cg-RX-API-DMAC7.html)
JP2017524733A5 (cg-RX-API-DMAC7.html)
JP2007505931A5 (cg-RX-API-DMAC7.html)
JP2013544786A5 (cg-RX-API-DMAC7.html)
UA121414C2 (uk) Нові анельовані феноксіацетаміди
JP2014500280A5 (cg-RX-API-DMAC7.html)
JP2012525369A5 (cg-RX-API-DMAC7.html)
WO2016057338A1 (en) Heteroarylamide inhibitors of tbk1
RU2013130027A (ru) Новые оксимовые производные в качестве модуляторов рецептора сфингозин 1-фосфата (s1p)
JP6099209B2 (ja) 黄斑変性の予防または治療用の医薬組成物
CN120204220A (zh) 治疗及/或预防纤维性疾病的胺基萘醌化合物